Information
Cell-mediated immune response diagnostics to early predict infections.
Loopdx has developed a patented diagnostic rapid test to identify bacterial bloodstream infections that is 10x faster and 3x more sensitive than the current market competitors. This will allow healthcare professionals to begin accurate treatment earlier – reducing the severity of the disease and decreasing the number of antibiotics and other drugs necessary for treatment.
Loopdx has developed a patented diagnostic rapid test to identify bacterial bloodstream infections that is 10x faster and 3x more sensitive than the current market competitors. This will allow healthcare professionals to begin accurate treatment earlier – reducing the severity of the disease and decreasing the number of antibiotics and other drugs necessary for treatment.